SARS-CoV-2 Process Control (Pellet)

SARS-CoV-2 Process Control can be used for SARS-CoV-2 assay development, full process control (including extraction), sample adequacy control and spike-in controls.

The SARS-CoV-2 Process Control (Pellet) is made with RNA transcripts containing diagnostically relevant targets (CDC and WHO consensus sequences) encapsulated in a phage protein. Nucleotides contained in each pellet (All positions in reference to GenBank Acc. NC_045512.2) • Orf1ab/RdRP: 12,690 ..12,797 | 13,342 ..13,460 | 14,080 ..14,186 | 15,431 ..15,530 • S (Spike): 18,778 ..18,909 | 24,354 ..24,900 • E (Envelope): 26,245 ..26,427 | 26,269 ..26,381 • N (Nucleocapsid): 28,237 ..29,280 Includes human respiratory epithelial cells RUO

Each kit contains 6 individually packaged lyophilized pellets.